222 related articles for article (PubMed ID: 26843222)
1. Spontaneously recovered severe thrombocytopaenia following zoledronic acid infusion for osteoporosis.
Kulkarni P; Cushman T; Donthireddy V; Rao S
BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26843222
[TBL] [Abstract][Full Text] [Related]
2. Medication-related osteonecrosis of the jaw after once-a-year intravenous zoledronic acid infusion for osteoporosis: Report of eight cases.
Favia G; Tempesta A; Limongelli L; Crincoli V; Maiorano E
Quintessence Int; 2016; 47(5):433-40. PubMed ID: 26665262
[TBL] [Abstract][Full Text] [Related]
3. Multicenter Study on Observation of Acute-phase Responses After Infusion of Zoledronic Acid 5 mg in Chinese Women with Postmenopausal Osteoporosis.
Ding Y; Zeng JC; Yin F; Zhang CL; Zhang Y; Li SX; Liu X; Zhang C; Xue QY; Lin H; Pei FX
Orthop Surg; 2017 Aug; 9(3):284-289. PubMed ID: 28960821
[TBL] [Abstract][Full Text] [Related]
4. Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.
Sieber P; Lardelli P; Kraenzlin CA; Kraenzlin ME; Meier C
Clin Drug Investig; 2013 Feb; 33(2):117-22. PubMed ID: 23184667
[TBL] [Abstract][Full Text] [Related]
5. Intravenous zoledronic acid for the treatment of osteoporosis.
Lewiecki EM
Curr Osteoporos Rep; 2008 Mar; 6(1):17-23. PubMed ID: 18430396
[TBL] [Abstract][Full Text] [Related]
6. Medication-related osteonecrosis of the jaws from once per year intravenous zoledronic acid (Reclast): report of 4 cases.
Lee CY; Suzuki JB
Implant Dent; 2015 Apr; 24(2):227-31. PubMed ID: 25734948
[TBL] [Abstract][Full Text] [Related]
7. [Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project].
Dalle Carbonare L; Bertoldo F; Lo Cascio V
Reumatismo; 2009; 61(1):54-64. PubMed ID: 19370189
[TBL] [Abstract][Full Text] [Related]
8. First cases of calcium pyrophosphate deposition disease after zoledronic acid therapy.
Couture G; Delzor F; Bagheri H; Micallef J; Ruyssen-Witrand A; Laroche M
Joint Bone Spine; 2017 Mar; 84(2):213-215. PubMed ID: 27939801
[TBL] [Abstract][Full Text] [Related]
9. [Fracture prevention in postmenopausal women with osteoporosis by an annual infusion of zoledronic acid].
Geusens PP; Lems WF
Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1445-8. PubMed ID: 17633971
[TBL] [Abstract][Full Text] [Related]
10. Zoledronic acid: a review of its use in the treatment of osteoporosis.
Deeks ED; Perry CM
Drugs Aging; 2008; 25(11):963-86. PubMed ID: 18947264
[TBL] [Abstract][Full Text] [Related]
11. [Zoledronic acid for preventing fractures. HORIZON trial (Health Outcomes and Reduced Incidence with Zoledronic acid ONce yearly)].
Ringe JD; Nitschmann S
Internist (Berl); 2008 Apr; 49(4):502-4. PubMed ID: 18305914
[No Abstract] [Full Text] [Related]
12. Zoledronic acid: new indication. No therapeutic advantage in postmenopausal osteoporosis.
Prescrire Int; 2008 Aug; 17(96):143. PubMed ID: 19480098
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic hypocalcemia following intravenous administration of zoledronic acid in a breast cancer patient.
Mishra A
J Postgrad Med; 2008; 54(3):237. PubMed ID: 18626181
[No Abstract] [Full Text] [Related]
14. Giant cell arteritis with visual loss following zoledronic acid infusion.
Metyas S; Ibrahim M; Solyman J; Yeter KC; Arkfeld DG
Int J Rheum Dis; 2014 Jan; 17(1):113-5. PubMed ID: 24472274
[TBL] [Abstract][Full Text] [Related]
15. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
Woodis CB
Ann Pharmacother; 2008 Jul; 42(7):1085-9. PubMed ID: 18505912
[TBL] [Abstract][Full Text] [Related]
16. Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass.
Hamdy RC
Drug Des Devel Ther; 2010 Nov; 4():321-35. PubMed ID: 21151620
[TBL] [Abstract][Full Text] [Related]
17. Respiratory complications associated with IV zoledronic acid infusion in the treatment of postmenopausal osteoporosis.
Taggart H; Cheng J; Archbold P
Osteoporos Int; 2010 Sep; 21(9):1621-2. PubMed ID: 19813042
[No Abstract] [Full Text] [Related]
18. Undetectable Urine Calcium in a Gastric Bypass Patient.
Campbell ST; Santen RJ; Bruns DE
Clin Chem; 2016 Aug; 62(8):1161. PubMed ID: 27471247
[No Abstract] [Full Text] [Related]
19. Zoledronic acid-induced severe lymphopenia.
Karpuz S
Osteoporos Int; 2023 Sep; 34(9):1653-1655. PubMed ID: 37322374
[TBL] [Abstract][Full Text] [Related]
20. [Effects of zoledronic acid on osteoporosis patients in Japan.].
Tanaka S
Clin Calcium; 2017; 27(2):257-261. PubMed ID: 28123128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
